IRCCS-I.R.S.T. srl Meldola /ID# 120255

Meldola 47014

0 studies enrolling now · 1 studies all time

What they study most

Triple Negative Breast Cancer

Studies at this site

• A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer — Completed